OTCMKTS:GSAC

GelStat (GSAC) Stock Price, News & Analysis

$0.0003
0.00 (0.00%)
(As of 05/3/2024 ET)
Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.0001
$0.0017
Volume
N/A
Average Volume
3.85 million shs
Market Capitalization
$185,394.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GSAC stock logo

About GelStat Stock (OTCMKTS:GSAC)

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.

GSAC Stock Price History

GSAC Stock News Headlines

$21,000 in profits in six weeks?
On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.
See More Headlines
Receive GSAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GelStat and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:GSAC
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
491,294,000
Market Cap
$185,394.00
Optionable
Not Optionable
Beta
2.48
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Javier G. Acosta
    CEO & Director
  • Mr. Charles F. Tarzian (Age 67)
    Chief Marketing Advisor
  • Dr. Roger K. Cady M.D.
    Chief Medical Advisor

GSAC Stock Analysis - Frequently Asked Questions

How have GSAC shares performed in 2024?

GelStat's stock was trading at $0.0003 at the beginning of the year. Since then, GSAC shares have increased by 0.0% and is now trading at $0.0003.
View the best growth stocks for 2024 here
.

How do I buy shares of GelStat?

Shares of GSAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:GSAC) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners